Patents by Inventor Isabelle Nadeau-Demers

Isabelle Nadeau-Demers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSPENSION CULTURE OF HUMAN EMBRYONIC STEM CELLS
    Publication number: 20240158741
    Abstract: This disclosure provides an improved system for culturing human embryonic stem cells. The cells are cultured in suspension so as to maximize the production capacity of the culture environment. The new culture system of this invention allows for bulk proliferation of hES cells in a more cost-effective manner, which facilitates commercial production of important products for use in human therapy.
    Type: Application
    Filed: January 24, 2024
    Publication date: May 16, 2024
    Inventors: Ramkumar Mandalam, Yan Li, Isabelle Nadeau-Demers
  • SUSPENSION CULTURE OF HUMAN EMBRYONIC STEM CELLS
    Publication number: 20200399592
    Abstract: This disclosure provides an improved system for culturing human embryonic stem cells. The cells are cultured in suspension so as to maximize the production capacity of the culture environment. The new culture system of this invention allows for bulk proliferation of hES cells in a more cost-effective manner, which facilitates commercial production of important products for use in human therapy.
    Type: Application
    Filed: April 29, 2020
    Publication date: December 24, 2020
    Applicant: Asterias Biotherapeutics, Inc.
    Inventors: Ramkumar Mandalam, Yan Li, Isabelle Nadeau-Demers
  • Suspension culture of human embryonic stem cells
    Patent number: 10676714
    Abstract: This disclosure provides an improved system for culturing human embryonic stem cells. The cells are cultured in suspension so as to maximize the production capacity of the culture environment. The new culture system of this invention allows for bulk proliferation of hES cells in a more cost-effective manner, which facilitates commercial production of important products for use in human therapy.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: June 9, 2020
    Assignee: Asterias Biotherapeutics, Inc.
    Inventors: Ramkumar Mandalam, Yan Li, Isabelle Nadeau-Demers
  • SUSPENSION CULTURE OF HUMAN EMBRYONIC STEM CELLS
    Publication number: 20190017014
    Abstract: This disclosure provides an improved system for culturing human embryonic stem cells. The cells are cultured in suspension so as to maximize the production capacity of the culture environment. The new culture system of this invention allows for bulk proliferation of hES cells in a more cost-effective manner, which facilitates commercial production of important products for use in human therapy.
    Type: Application
    Filed: February 12, 2018
    Publication date: January 17, 2019
    Inventors: Ramkumar Mandalam, Yan Li, Isabelle Nadeau-Demers
  • Suspension Culture of Human Embryonic Stem Cells
    Publication number: 20150307838
    Abstract: This disclosure provides an improved system for culturing human embryonic stem cells. The cells are cultured in suspension so as to maximize the production capacity of the culture environment. The new culture system of this invention allows for bulk proliferation of hES cells in a more cost-effective manner, which facilitates commercial production of important products for use in human therapy.
    Type: Application
    Filed: July 6, 2015
    Publication date: October 29, 2015
    Inventors: Ramkumar Mandalam, Yan Li, Isabelle Nadeau-Demers
  • Suspension culture of human embryonic stem cells
    Patent number: 9074181
    Abstract: This disclosure provides an improved system for culturing human embryonic stem cells. The cells are cultured in suspension so as to maximize the production capacity of the culture environment. The new culture system of this invention allows for bulk proliferation of hES cells in a more cost-effective manner, which facilitates commercial production of important products for use in human therapy.
    Type: Grant
    Filed: June 20, 2006
    Date of Patent: July 7, 2015
    Assignee: Asterias Biotherapeutics, Inc.
    Inventors: Ramkumar Mandalam, Yan Li, Isabelle Nadeau-Demers
  • Suspension Culture of Human Embryonic Stem Cells
    Publication number: 20100144033
    Abstract: This disclosure provides an improved system for culturing human embryonic stem cells. The cells are cultured in suspension so as to maximize the production capacity of the culture environment. The new culture system of this invention allows for bulk proliferation of hES cells in a more cost-effective manner, which facilitates commercial production of important products for use in human therapy.
    Type: Application
    Filed: June 20, 2006
    Publication date: June 10, 2010
    Inventors: Ramkumar Mandalam, Yan Li, Isabelle Nadeau-Demers